SS
WST icon

SBI Securities’s West Pharmaceutical WST Stock Holding History

SBI Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.38K Sell
15
-10
-40% -$3.06K ﹤0.01% 2139
2026
Q1 		$6.27K Sell
25
-805
-97% -$200K ﹤0.01% 1935
2025
Q4 		$228K Buy
830
+170
+26% +$46.5K 0.01% 593
2025
Q3 		$173K Buy
660
+618
+1,471% +$150K ﹤0.01% 669
2025
Q2 		$9.19K Sell
42
-3
-7% -$641 ﹤0.01% 1735
2025
Q1 		$10.1K Buy
45
+6
+15% +$1.65K ﹤0.01% 1603
2024
Q4 		$12.8K Buy
+39
New +$12.3K ﹤0.01% 1541

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

SBI Securities's WST Position: Q2 2026 in Review

SBI Securities reduced its West Pharmaceutical (WST) stake by 40% in Q2 2026, selling an estimated $3.06K and leaving 15 shares worth $5.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2139.

SBI Securities first reported a position in WST in Q4 2024 and has held it in 7 quarters since. The position peaked at $228K in Q4 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • SBI Securities held 15 shares of West Pharmaceutical worth $5.38K as of Q2 2026.
  • SBI Securities sold 10 West Pharmaceutical shares in Q2 2026, an estimated $3.06K.
  • West Pharmaceutical made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2139 holding.
  • SBI Securities first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's West Pharmaceutical position peaked at $228K in Q4 2025.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.